ArticleInternational journal of ophthalmology2023

Recurrence risk factors of intravitreal ranibizumab monotherapy in retinopathy of prematurity: a retrospective study at one center.

Feng-Yue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.